Based on 2 analysts offering 12 month price targets for Artelo Biosciences Inc
Min Forecast
$5.00+334.78%
Avg Forecast
$5.50+378.26%
Max Forecast
$6.00+421.74%
Should I buy or sell ARTL stock?
Based on 2 analysts offering ratings for Artelo Biosciences Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ARTL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ARTL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their ARTL stock forecasts and price targets.
ARTL stock forecasts by analyst
Analyst / Firm
Rating
Action
Price Target
Upside/Downside
Date
Analyst Color
locked
locked
$00.00
+00.00%
2025-01-14
locked
locked
$00.00
+00.00%
2024-12-09
1 of 1
Forecast return on equity
Is ARTL forecast to generate an efficient return?
Company
N/A
Industry
151.81%
Market
68.86%
Forecast return on assets
Is ARTL forecast to generate an efficient return on assets?
Company
N/A
Industry
22.99%
ARTL earnings per share forecast
What is ARTL's earnings per share in the next 1 years based on estimates from 2 analysts?
Is Artelo Biosciences Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: ARTL) stock is to Strong Buy ARTL stock.
Out of 2 analysts, 1 (50%) are recommending ARTL as a Strong Buy, 1 (50%) are recommending ARTL as a Buy, 0 (0%) are recommending ARTL as a Hold, 0 (0%) are recommending ARTL as a Sell, and 0 (0%) are recommending ARTL as a Strong Sell.
What is ARTL's earnings growth forecast for 2025-2025?
(NASDAQ: ARTL) Artelo Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 20.35%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 25.22%.
Artelo Biosciences's earnings in 2025 is -$9,121,000.
In 2025, ARTL is forecast to generate -$3,453,639 in earnings, with the lowest earnings forecast at -$5,196,597 and the highest earnings forecast at -$1,710,681.
What is ARTL's forecast return on equity (ROE) for 2025-2027?
(NASDAQ: ARTL) forecast ROE is N/A, which is considered weak.
What is ARTL's Price Target?
According to 2 Wall Street analysts that have issued a 1 year ARTL price target, the average ARTL price target is $5.50, with the highest ARTL stock price forecast at $6.00 and the lowest ARTL stock price forecast at $5.00.
On average, Wall Street analysts predict that Artelo Biosciences's share price could reach $5.50 by Jan 14, 2026. The average Artelo Biosciences stock price prediction forecasts a potential upside of 378.26% from the current ARTL share price of $1.15.
What is ARTL's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: ARTL) Artelo Biosciences's current Earnings Per Share (EPS) is -$2.87. In 2025, ARTL's EPS is forecast to hit -$1.07 (min: -$1.61, max: -$0.53).
What is ARTL's forecast return on assets (ROA) for 2025-2027?
(NASDAQ: ARTL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 22.99%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.